Blood cancers, Cell type, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial looked at a drug called romidepsin for peripheral T cell lymphoma that has continued to grow during treatment or has come back after treatment.
Recruitment start: 1 June 2007
Recruitment end: 17 November 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Donald MacDonald
Celgene
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 26 Nov 2014
CRUK internal database number: 4211
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
